With over thirty years of scientific and administrative experience, Janie partners with faculty teams and university leaders to forge research-based alliances between academia and industry, focused on health and life sciences. These partnerships leverage Yale's research excellence to advance translational science at scale.

Janie's scientific career has spanned the intersection of science and service, applying high-throughput molecular technologies — including protein folding, genome sequencing, gene expression, and protein microarray profiling — to diverse biological and biomedical questions across industry, academia, and nonprofit research institutions. As Director of Yale University's Center for Molecular Discovery for thirteen years, she translated novel disease-target concepts into small molecule and siRNA screening and hit validation programs, with Faculty Director Craig Crews.

Since 2016, Janie has served on the External Oversight Committee of the NIH Blueprint Neurotherapeutic Network Program, reviewing portfolio programs that advance small molecule therapeutics for neurological diseases through Phase I clinical trials.

Janie holds a PhD in Molecular Biophysics and Biochemistry from Yale University and completed her postdoctoral fellowship in genomic sequencing at The Institute for Genomic Research, now part of the J. Craig Venter Institute.